Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between the two are due to...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Structural basis for substrate recognition and inhibition of thioredoxin glutathione reductase from Schistosoma japonicum: Implications for antiparasitic development.

PLoS pathogens·2026
Same author

Reproductive factors and lung cancer risk in never-smoking women: a prospective cohort study.

BMC cancer·2026
Same author

Brain and central nervous system cancer burden in children across Asia.

iScience·2026
Same author

The disease burden of inguinal, femoral, and abdominal hernias in children from low- and middle-income countries, 1990-2023 with projections to 2050: a systematic analysis of the Global Burden of Disease Study.

Translational pediatrics·2026
Same author

Recent progress of plant-derived extracellular vesicle-like nanoparticles integrated with biomaterials for skin repair.

Journal of nanobiotechnology·2026
Same author

An interpretable ultrasound-based deep learning system for early breast cancer in a Chinese population.

Insights into imaging·2026
Same journal

Integrating health economics and implementation science: a call to action.

BMC medical research methodology·2026
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

Reducing selection bias risk to enhance RCT validity: sandwich mixed randomization outperforms permuted block design.

Bingshun Wang1, Xiaojin Wang2, Changyu Ni2

  • 1Institute of Clinical Medicine, Ruijin Hospital Luwan Branch, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. wangbingshun@sjtu.edu.cn.

BMC Medical Research Methodology
|May 14, 2026
PubMed
Summary
This summary is machine-generated.

Permuted block design (PBD) in randomized controlled trials (RCTs) risks selection bias due to predictable sequences. Sandwich Mixed Randomization (SMR) offers a simple, effective alternative, maintaining balance while significantly reducing bias risk.

Keywords:
Allocation unpredictabilityClinical trial methodologyPermuted block designRandomized controlled trialsSandwich Mixed RandomizationSelection bias

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Related Experiment Videos

Last Updated: May 16, 2026

A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Epidemiology

Background:

  • Random allocation is crucial for unbiased treatment assignment in randomized controlled trials (RCTs).
  • Permuted block design (PBD), despite its widespread use (~75% of RCTs), suffers from predictable allocation sequences, compromising randomization integrity.
  • Existing alternatives to PBD have not gained broad acceptance, highlighting the need for a simple, universally applicable method that balances treatment groups and improves unpredictability.

Purpose of the Study:

  • To introduce and evaluate Sandwich Mixed Randomization (SMR), a novel method designed to enhance allocation unpredictability while maintaining treatment group balance.
  • To compare the performance of SMR against fixed- and variable-sized PBD using key metrics such as treatment imbalance and allocation predictability.
  • To quantify the risk of selection bias associated with PBD and SMR.

Main Methods:

  • SMR integrates complete randomization with PBD within a "sandwich" framework for improved unpredictability and balance.
  • Monte Carlo simulations were used to evaluate SMR in 1:1 two-arm open-label RCTs of varying sizes (n=48, 240, 1,200).
  • Performance metrics included absolute group size difference, proportion of correct allocation guesses, and relative excess risk of selection bias compared to complete randomization.

Main Results:

  • PBD ensures perfect balance but shows high allocation predictability (correct guesses >68%), significantly exceeding the 50% benchmark of complete randomization.
  • SMR maintains balanced group sizes while reducing correct guess proportions to ~56% (small trials) and ~53% (larger trials).
  • SMR reduced the risk of selection bias by >66% (small trials) and >81% (larger trials) compared to variable-sized PBD, with a consistent PBD-to-SMR risk ratio for bias exceeding 3 across all sample sizes.

Conclusions:

  • The predictability of PBD, irrespective of block size, substantially elevates the risk of selection bias in RCTs.
  • SMR presents a universally applicable, low-effort alternative to PBD, significantly mitigating selection bias risk across various RCT designs.
  • Adopting SMR enhances randomization integrity and internal validity, reinforcing the RCT's role in generating reliable clinical evidence.